All Episodes
The Uromigos — 23 episodes
Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates
Episode 516: The Influence of Hypoxia on Response and Resistance in RCC
Episode 515: PROTEUS - A Reflection on the Data and Controversies with Neha Vapiwala
Episode 514: Artificial Intelligence in Cancer Drug Development
Episode 513: Trials and Tribulations of Investigator-initiated Research
Episode 512: ENZA-P Nature Medicine translational data
Episode 510: ADCs in Prostate Cancer
Episode 509: ASCO 2026 Review
Episode 508: ASCO 2026 Plenary - PROTEUS: ADT +/- Apalutamide in high-risk Localized Prostate Cancer
Episode 507: ASCO 2026 - TALAPRO-3
Episode 506: ASCO 2026 - How do we measure quality of life in GU patients?
Episode 505 : ASCO 2026 - RAMPART
Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer
Episode 499: APCCC 2026 - Radioligands in Prostate Cancer
Episode 503: ASCO 2026 Preview
Episode 502: AUA 2026 and FDA bladder cancer meeting
Episode 501: APCCC 2026 - Biochemically-relapsed Prostate cancer
Episode 500: RAS Inhibition in Pancreatic Cancer (yes this is the Uromigos podcast..)
Episode 499: APCCC 2026 - Radioligands
Episode 498: APCCC 2026 - mCRPC
Episode 497: Reflections on the capivasertib ODAC
Episode 496: APCCC 2026 - mHSPC Landscape
Episode 495: APCCC 2026 - Locally-advanced Prostate Cancer